Guobang Pharmaceutical announced that the shareholders holding 5% or more of the shares, Shangrao Zhejiang Mintou Henghua Venture Capital Partnership (limited partnership) and Zhejiang Silk Road Industrial Investment Fund Partnership (limited partnership) plan to reduce their holdings by no more than 3%.
国邦医药：持股5%以上股东拟减持不超过3%
Guobang Pharmaceutical: Shareholders holding 5% or more plan to reduce their holdings by no more than 3%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.